In the past 30 years, the survival rate for breast cancer has improved by about 40%, one of the highest survival rates of any cancer. The increase in survival is, in part, due to advances in screening technology as well as improvement in cancer treatment and a better understanding of the biology of cancer. All of which have had an impact on survival.

In this episode of The Onco’Zine Brief Peter Hofland, Ph.D. talks with talking with Stephen Malamud, MD, who is the regional director of medical oncology at Nuvance Health, a health network with hospitals, medical practices, and care centers located throughout New York’s Hudson Valley and Western Connecticut.

Hofland and Malamud talk about some of the results of studies presented during the 2021 San Antonio Breast Cancer Symposium, held December 7 – 10, 2021 in San Antonio, Texas, and virtually via streaming media. For this episode of The Onco’Zine Brief, the producers and editors selected just a few key presentations. In each case, Hofland and Malamud briefly discuss the study as well as how the results may improve the health-related Quality of Life (hrQoL) of patients. They also try to answer if the study results may change the way medicine is practiced.